Cost-effectiveness analysis of a hepatitis B vaccination catch-up program among children in Shandong Province, China.
Hum Vaccin Immunother
; 10(10): 2983-91, 2014.
Article
em En
| MEDLINE
| ID: mdl-25483678
Palavras-chave
Anti-HBs, Antibody to Hepatitis B Surface Antigen; CC, Compensated Cirrhosis; CHB, Chronic Hepatitis B; Cost-effectiveness Analysis; DC, Decompensated Cirrhosis; GAVI, Global Alliance on Vaccines and Immunization; GDP, Gross Domestic Product; BCR, Benefit-Cost Ratio; HBV, Hepatitis B Virus; HBsAg, Hepatitis B Surface Antigen; HCC, Hepatocellular Carcinoma; HRQoL, Health-Related Quality of Life; HepB3, 3-dose Coverage of Hepatitis B Vaccine; ICER; ICER, Incremental Cost-Effectiveness Ratio; LT-1, the Year of Liver Transplantation; LT-2, Years after Liver Transplantation; MOH, Ministry of Health; NNDRS, National Notifiable Diseases Reporting System; QALY; QALYs, Quality-Adjusted Life Years; catch-up program; hepatitis B virus; vaccination
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Vacinação em Massa
/
Análise Custo-Benefício
/
Vacinas contra Hepatite B
/
Programas de Imunização
/
Hepatite B
Tipo de estudo:
Evaluation_studies
/
Health_economic_evaluation
/
Prognostic_studies
Limite:
Adolescent
/
Child
/
Female
/
Humans
/
Male
País/Região como assunto:
Asia
Idioma:
En
Revista:
Hum Vaccin Immunother
Ano de publicação:
2014
Tipo de documento:
Article
País de afiliação:
China